{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:30:41Z","timestamp":1772119841386,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:00:00Z","timestamp":1761696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11096-025-02032-9","type":"journal-article","created":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T08:24:54Z","timestamp":1761726294000},"page":"2072-2082","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring pediatricians\u2019 off-label prescribing behavior in China: A theory of planned behavior-based study"],"prefix":"10.1007","volume":"47","author":[{"given":"Yueqin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuelin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Ramalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,29]]},"reference":[{"issue":"1","key":"2032_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1186\/s12913-023-09293-y","volume":"23","author":"W Si","year":"2023","unstructured":"Si W, Ma P. Judicial and legislative practice and related suggestions on off-label drug use in China. BMC Health Serv Res. 2023;23(1):312.","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"2032_CR2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1517\/14740338.5.5.703","volume":"5","author":"L Cuzzolin","year":"2006","unstructured":"Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Expert Opin Drug Saf. 2006;5(5):703\u201318.","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"2032_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2023.101704","volume":"31","author":"S Lee","year":"2023","unstructured":"Lee S, Yang MH, Kim JS, et al. Evaluation of off-label medication use and drug safety in a pediatric intensive care unit. Saudi Pharm J. 2023;31(9):101704.","journal-title":"Saudi Pharm J"},{"key":"2032_CR4","doi-asserted-by":"publisher","first-page":"964","DOI":"10.3389\/fphar.2020.00964","volume":"11","author":"JML Vieira","year":"2020","unstructured":"Vieira JML, de Matos GC, da Silva FAB, et al. Serious adverse drug reactions and safety signals in children: a nationwide database study. Front Pharmacol. 2020;11:964.","journal-title":"Front Pharmacol"},{"issue":"2","key":"2032_CR5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1136\/adc.2009.158485","volume":"95","author":"MA Ghaleb","year":"2010","unstructured":"Ghaleb MA, Barber N, Franklin BD, et al. The incidence and nature of prescribing and medication administration errors in paediatric inpatients. Arch Dis Child. 2010;95(2):113\u20138.","journal-title":"Arch Dis Child"},{"issue":"1","key":"2032_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s12887-019-1875-y","volume":"19","author":"A Sutherland","year":"2019","unstructured":"Sutherland A, Phipps DL, Tomlin S, et al. Mapping the prevalence and nature of drug related problems among hospitalised children in the United Kingdom: a systematic review. BMC Pediatr. 2019;19(1):486.","journal-title":"BMC Pediatr"},{"issue":"5","key":"2032_CR7","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3892\/etm.2024.12701","volume":"28","author":"X Yuan","year":"2024","unstructured":"Yuan X, Gao J, Yang L, et al. Off-label and unapproved pediatric drug utilization: a meta-analysis. Exp Ther Med. 2024;28(5):412.","journal-title":"Exp Ther Med"},{"issue":"8","key":"2032_CR8","first-page":"1640","volume":"14","author":"KS Dudhal","year":"2024","unstructured":"Dudhal KS, Kadhe NG, Pawar S. Evaluation of adverse drug reactions to off-label use of drugs in children from spontaneously reported cases at a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2024;14(8):1640.","journal-title":"Natl J Physiol Pharm Pharmacol"},{"key":"2032_CR9","doi-asserted-by":"publisher","first-page":"1553221","DOI":"10.3389\/fphar.2025.1553221","volume":"16","author":"Z Ji","year":"2025","unstructured":"Ji Z, Wang X, Wang J. Analysis of off-label drug use and its influencing factors in pediatric patients undergoing otolaryngology, head, and neck surgery. Front Pharmacol. 2025;16:1553221.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2032_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/20523211.2025.2472221","volume":"18","author":"KE Blankart","year":"2025","unstructured":"Blankart KE, Lichtenberg FR. Prevalence and relationship with health of off-label and contraindicated drug use in the United States: a cross-sectional study. J Pharm Policy Pract. 2025;18(1):2472221.","journal-title":"J Pharm Policy Pract"},{"key":"2032_CR11","doi-asserted-by":"publisher","first-page":"1574412","DOI":"10.3389\/fphar.2025.1574412","volume":"16","author":"FT Alsulami","year":"2025","unstructured":"Alsulami FT, Alqarni YS, Alruqayb WS, et al. Understanding community pharmacists\u2019 intentions to report adverse drug reactions in Saudi Arabia: a theory of planned behavior analysis. Front Pharmacol. 2025;16:1574412.","journal-title":"Front Pharmacol"},{"key":"2032_CR12","doi-asserted-by":"publisher","first-page":"1382903","DOI":"10.3389\/fmed.2024.1382903","volume":"11","author":"SS Guraya","year":"2024","unstructured":"Guraya SS, Clarke E, Sadeq A, et al. Validating a theory of planned behavior questionnaire for assessing changes in professional behaviors of medical students. Front Med Lausanne. 2024;11:1382903.","journal-title":"Front Med Lausanne"},{"issue":"1","key":"2032_CR13","doi-asserted-by":"publisher","DOI":"10.2196\/55391","volume":"9","author":"BD Naughton","year":"2025","unstructured":"Naughton BD. Planned behavior in the United Kingdom and Ireland online medicine purchasing context: mixed methods survey study. JMIR formative Res. 2025;9(1):e55391.","journal-title":"JMIR formative Res"},{"issue":"1","key":"2032_CR14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11096-022-01490-9","volume":"45","author":"D Stewart","year":"2023","unstructured":"Stewart D, Al Hail M, Al-Shaibi S, et al. A scoping review of theories used to investigate clinician adherence to clinical practice guidelines. Int J Clin Pharm. 2023;45(1):52\u201363.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"2032_CR15","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1186\/s12889-024-20651-1","volume":"24","author":"A Kamyab","year":"2024","unstructured":"Kamyab A, Bijani M, Jormand H, et al. Education based on the theory of planned behavior to improve medication regimen adherence, hope and marital quality in patients with substance use disorder. BMC Public Health. 2024;24(1):3173.","journal-title":"BMC Public Health"},{"issue":"2","key":"2032_CR16","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0749-5978(91)90020-T","volume":"50","author":"I Ajzen","year":"1991","unstructured":"Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50(2):179\u2013211.","journal-title":"Organ Behav Hum Decis Process"},{"issue":"4","key":"2032_CR17","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/hbe2.195","volume":"2","author":"I Ajzen","year":"2020","unstructured":"Ajzen I. The theory of planned behavior: frequently asked questions. Hum Behav Emerg Technol. 2020;2(4):314\u201324.","journal-title":"Hum Behav Emerg Technol"},{"issue":"14","key":"2032_CR18","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1056\/NEJMp0802107","volume":"358","author":"RS Stafford","year":"2008","unstructured":"Stafford RS. Regulating off-label drug use\u2014rethinking the role of the FDA. N Engl J Med. 2008;358(14):1427\u20139.","journal-title":"N Engl J Med"},{"issue":"19","key":"2032_CR19","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1001\/archinternmed.2009.314","volume":"169","author":"EA Largent","year":"2009","unstructured":"Largent EA, Miller FG, Pearson SD. Going off-label without venturing off-course: evidence and ethical off-label prescribing. Arch Intern Med. 2009;169(19):1745\u20137.","journal-title":"Arch Intern Med"},{"key":"2032_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.785419","volume":"12","author":"D Wang","year":"2021","unstructured":"Wang D, Zhang X, Chen H, et al. Applying theory of planned behavior to understand physicians\u2019 shared decision-making with patients with acute respiratory infections in primary care: a cross-sectional study. Front Pharmacol. 2021;12:785419.","journal-title":"Front Pharmacol"},{"issue":"1","key":"2032_CR21","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1186\/s12913-023-09946-y","volume":"23","author":"YH Liao","year":"2023","unstructured":"Liao YH, Tang KP, Chou CY, et al. Assessment of factors influencing physicians\u2019 intention to prescribe transfusion using the theory of planned behavior. BMC Health Serv Res. 2023;23(1):973.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"2032_CR22","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s10865-015-9644-3","volume":"38","author":"A Rich","year":"2015","unstructured":"Rich A, Brandes K, Mullan B, et al. Theory of planned behavior and adherence in chronic illness: a meta-analysis. J Behav Med. 2015;38(4):673\u201388.","journal-title":"J Behav Med"},{"issue":"8","key":"2032_CR23","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.21037\/tp-24-198","volume":"13","author":"M Meng","year":"2024","unstructured":"Meng M, Hu J, Lei W, et al. The implementation of the guideline for the management of pediatric off-label use of drugs in China: a cross-sectional study. Transl Pediatr. 2024;13(8):1425.","journal-title":"Transl Pediatr"},{"issue":"6","key":"2032_CR24","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1038\/s41390-024-03509-5","volume":"97","author":"I Bosch","year":"2025","unstructured":"Bosch I, Siebel H, Heiser M, et al. Decision-making for children and adolescents: a scoping review of interventions increasing participation in decision-making. Pediatr Res. 2025;97(6):1840\u201354.","journal-title":"Pediatr Res"},{"issue":"4","key":"2032_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s43441-025-00793-z","volume":"59","author":"JS Barrett","year":"2025","unstructured":"Barrett JS, Turner MA. Consideration for assessing data\/models\/tools expiration supporting drug development and clinical decision making. Ther Innov Regul Sci. 2025;59(4):707\u201317.","journal-title":"Ther Innov Regul Sci"},{"issue":"1","key":"2032_CR26","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1007\/s11096-021-01303-5","volume":"44","author":"B Guidi","year":"2022","unstructured":"Guidi B, Parziale A, Nocco L, et al. Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions: comparative regulation framework of off label prescriptions in pediatrics: a review. Int J Clin Pharm. 2022;44(1):264\u20139.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"2032_CR27","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1542\/peds.2006-0034","volume":"119","author":"JK Wang","year":"2007","unstructured":"Wang JK, Herzog NS, Kaushal R, et al. Prevention of pediatric medication errors by hospital pharmacists and the potential benefit of computerized physician order entry. Pediatrics. 2007;119(1):e77\u201385.","journal-title":"Pediatrics"},{"issue":"7227","key":"2032_CR28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1136\/bmj.320.7227.79","volume":"320","author":"S Conroy","year":"2000","unstructured":"Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ. 2000;320(7227):79\u201382.","journal-title":"BMJ"},{"issue":"10","key":"2032_CR29","doi-asserted-by":"publisher","first-page":"544","DOI":"10.5694\/j.1326-5377.2006.tb00689.x","volume":"185","author":"M Gazarian","year":"2006","unstructured":"Gazarian M, Kelly M, McPhee JR, et al. Off-label use of medicines: consensus recommendations for evaluating appropriateness. Med J Aust. 2006;185(10):544\u20138.","journal-title":"Med J Aust"},{"key":"2032_CR30","unstructured":"Ministry of Health of the People\u2019s Republic of China. Management measures for prescriptions. Beijing. 2007. https:\/\/www.nhc.gov.cn\/wjw\/c100221\/202201\/6a4ee53e4a3a407fbd9f520e1e2662c5\/files\/%E5%A4%84%E6%96%B9%E7%AE%A1%E7%90%86%E5%8A%9E%E6%B3%95.pdf. Accessed 1 Sept 2025."}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-02032-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-025-02032-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-025-02032-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:07:49Z","timestamp":1763554069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-025-02032-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,29]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2032"],"URL":"https:\/\/doi.org\/10.1007\/s11096-025-02032-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7351063\/v1","asserted-by":"object"}]},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,29]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was reviewed and confirmed by the Ethics Committee of Beijing Aerospace General Hospital to meet the criteria for exemption from a full ethics review (filing no. 2025-40, filing date: May 25, 2024).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}